Table 3.
Prevalence of HuNoV RNA in saliva samples of studied subjects, according to the genotype to which they were exposed.
| Symptomatic Cases | Asymptomatic Exposed Subjects | Total | |||||
|---|---|---|---|---|---|---|---|
| Genotype | No. of Outbreaks | No. of Analyzed Samples | No. of Positive Samples (%) | No. of Analyzed Samples | No. of Positive Samples (%) | No. of Analyzed Samples | No. of Positive Samples (%) |
| GI.1[P1] | 2 | 25 | 0 (0%) | 15 | 0 (0%) | 40 | 0 (0%) |
| GI.3[P13] | 1 | 10 | 0 (0%) | 10 | 0 (0%) | 20 | 0 (0%) |
| GI.4[P4] | 4 | 25 | 0 (0%) | 20 | 0 (0%) | 45 | 0 (0%) |
| GI.6[P11] | 2 | 11 | 0 (0%) | 5 | 0 (0%) | 16 | 0 (0%) |
| GI.3[P13] + GI.2 | 1 | 4 | 0 (0%) | 4 | 0 (0%) | 8 | 0 (0%) |
| Total GI | 10 | 75 | 0 (0%) | 54 | 0 (0%) | 129 | 0 (0%) |
| GII.1[P33] | 1 | 13 | 0 (0%) | 18 | 0 (0%) | 31 | 0 (0%) |
| GII.2[P16] | 3 | 23 | 6 (26.1%) | 10 | 0 (0%) | 33 | 6 (18.2%) |
| GII.4[P16] | 4 | 30 | 5 (16.7%) | 14 | 2 (14.2%) | 44 | 7 (15.9%) |
| GII.4[P31] | 2 | 17 | 3 (17.6%) | 0 | 0 (0%) | 17 | 3 (17.6%) |
| GII.17[P17] | 6 | 57 | 11 (19.3%) | 54 | 3 (5.5%) | 111 | 14 (12.6%) |
| Total GII | 16 | 140 | 25 (17.9%) | 96 | 5 (5.2%) | 236 | 30 (12.7%) |